Nuveen Asset Management’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $22.7M | Sell |
915,151
-189,759
| -17% | -$4.7M | 0.01% | 1111 |
|
|
2024
Q3 | $31.5M | Sell |
1,104,910
-39,939
| -3% | -$1.14M | 0.01% | 901 |
|
|
2024
Q2 | $30.2M | Buy |
1,144,849
+40,571
| +4% | +$1.07M | 0.01% | 870 |
|
|
2024
Q1 | $35.7M | Sell |
1,104,278
-122,988
| -10% | -$3.97M | 0.01% | 811 |
|
|
2023
Q4 | $51.7M | Buy |
1,227,266
+199,050
| +19% | +$8.39M | 0.02% | 591 |
|
|
2023
Q3 | $39.5M | Buy |
1,028,216
+240,965
| +31% | +$9.25M | 0.01% | 660 |
|
|
2023
Q2 | $14.9M | Buy |
787,251
+264,855
| +51% | +$5.02M | 0.01% | 1260 |
|
|
2023
Q1 | $8.1M | Buy |
522,396
+198,478
| +61% | +$3.08M | ﹤0.01% | 1618 |
|
|
2022
Q4 | $5.75M | Buy |
323,918
+145,490
| +82% | +$2.58M | ﹤0.01% | 1831 |
|
|
2022
Q3 | $995K | Sell |
178,428
-3,089
| -2% | -$17.2K | ﹤0.01% | 2754 |
|
|
2022
Q2 | $708K | Sell |
181,517
-41,568
| -19% | -$162K | ﹤0.01% | 2927 |
|
|
2022
Q1 | $1.32M | Sell |
223,085
-148,865
| -40% | -$883K | ﹤0.01% | 2691 |
|
|
2021
Q4 | $3.17M | Buy |
371,950
+12,643
| +4% | +$108K | ﹤0.01% | 2346 |
|
|
2021
Q3 | $3.12M | Sell |
359,307
-38,075
| -10% | -$331K | ﹤0.01% | 2454 |
|
|
2021
Q2 | $4.2M | Buy |
397,382
+31,199
| +9% | +$330K | ﹤0.01% | 2333 |
|
|
2021
Q1 | $5.87M | Sell |
366,183
-59,483
| -14% | -$954K | ﹤0.01% | 2097 |
|
|
2020
Q4 | $19.7M | Buy |
425,666
+68,686
| +19% | +$3.17M | 0.01% | 1282 |
|
|
2020
Q3 | $12.6M | Buy |
356,980
+167,829
| +89% | +$5.91M | ﹤0.01% | 1371 |
|
|
2020
Q2 | $4.61M | Buy |
+189,151
| New | +$4.61M | ﹤0.01% | 1938 |
|